...
search icon
wgs-img

GeneDx Holdings Corp. Share Price

WGS
NSQ
$92.04
+$1.01
(1.11%)
1D
Industry: Health Care Equipment & Supplies Sector: Health Care

GeneDx Holdings Corp. Analyst Forecast

GeneDx Holdings Corp. Share Price Chart

GeneDx Holdings Corp. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.63B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
819.5455
Volume info-icon
This is the total number of shares traded during the most recent trading day.
419.26K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.02
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$55.17 L
$170.87 H
$92.04

About GeneDx Holdings Corp., Common Stock

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut. more

Industry: Health Care Equipment & SuppliesSector: Health Care

GeneDx Holdings Corp. Stock Returns

Time FrameWGSSectorS&P500
1-Week Return1.16%0.72%-1.31%
1-Month Return-7.2%1.27%0.78%
3-Month Return-27.12%3.13%3.46%
6-Month Return-26.53%15.81%6.19%
1-Year Return-17.97%8.89%11.68%
3-Year Return488.87%20.79%71.21%
5-Year Return-88.27%35.89%74.81%
10-Year Return-71.4%138.44%256.59%

GeneDx Holdings Corp. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue179.32M212.19M234.69M202.57M305.45M[{"date":"2020-12-31","value":58.71,"profit":true},{"date":"2021-12-31","value":69.47,"profit":true},{"date":"2022-12-31","value":76.84,"profit":true},{"date":"2023-12-31","value":66.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue175.30M228.80M261.44M112.56M111.05M[{"date":"2020-12-31","value":67.05,"profit":true},{"date":"2021-12-31","value":87.51,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":43.05,"profit":true},{"date":"2024-12-31","value":42.48,"profit":true}]
Gross Profit4.03M(16.60M)(26.75M)90.01M194.40M[{"date":"2020-12-31","value":2.07,"profit":true},{"date":"2021-12-31","value":-8.54,"profit":false},{"date":"2022-12-31","value":-13.76,"profit":false},{"date":"2023-12-31","value":46.3,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin2.25%(7.82%)(11.40%)44.43%63.64%[{"date":"2020-12-31","value":3.53,"profit":true},{"date":"2021-12-31","value":-12.29,"profit":false},{"date":"2022-12-31","value":-17.91,"profit":false},{"date":"2023-12-31","value":69.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses246.02M429.55M640.90M270.60M217.61M[{"date":"2020-12-31","value":38.39,"profit":true},{"date":"2021-12-31","value":67.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":42.22,"profit":true},{"date":"2024-12-31","value":33.95,"profit":true}]
Operating Income(241.99M)(446.15M)(667.65M)(180.60M)(23.21M)[{"date":"2020-12-31","value":-24199400000,"profit":false},{"date":"2021-12-31","value":-44614900000,"profit":false},{"date":"2022-12-31","value":-66765200000,"profit":false},{"date":"2023-12-31","value":-18059600000,"profit":false},{"date":"2024-12-31","value":-2321300000,"profit":false}]
Total Non-Operating Income/Expense(1.31M)198.00M68.95M5.02M(32.45M)[{"date":"2020-12-31","value":-0.66,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.82,"profit":true},{"date":"2023-12-31","value":2.53,"profit":true},{"date":"2024-12-31","value":-16.39,"profit":false}]
Pre-Tax Income(241.34M)(245.39M)(598.03M)(176.69M)(52.63M)[{"date":"2020-12-31","value":-24134000000,"profit":false},{"date":"2021-12-31","value":-24539000000,"profit":false},{"date":"2022-12-31","value":-59803200000,"profit":false},{"date":"2023-12-31","value":-17669300000,"profit":false},{"date":"2024-12-31","value":-5262900000,"profit":false}]
Income Taxes5.10M21.57M(49.05M)(926.00K)(343.00K)[{"date":"2020-12-31","value":23.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-227.4,"profit":false},{"date":"2023-12-31","value":-4.29,"profit":false},{"date":"2024-12-31","value":-1.59,"profit":false}]
Income After Taxes(246.44M)(266.96M)(548.98M)(175.77M)(52.29M)[{"date":"2020-12-31","value":-24643600000,"profit":false},{"date":"2021-12-31","value":-26696044200,"profit":false},{"date":"2022-12-31","value":-54898000000,"profit":false},{"date":"2023-12-31","value":-17576700000,"profit":false},{"date":"2024-12-31","value":-5228600000,"profit":false}]
Income From Continuous Operations(241.34M)(245.39M)(548.98M)(175.77M)(52.29M)[{"date":"2020-12-31","value":-24134000000,"profit":false},{"date":"2021-12-31","value":-24539000000,"profit":false},{"date":"2022-12-31","value":-54898000000,"profit":false},{"date":"2023-12-31","value":-17576700000,"profit":false},{"date":"2024-12-31","value":-5228600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(241.34M)(245.39M)(548.98M)(175.77M)(52.29M)[{"date":"2020-12-31","value":-24134000000,"profit":false},{"date":"2021-12-31","value":-24539000000,"profit":false},{"date":"2022-12-31","value":-54898000000,"profit":false},{"date":"2023-12-31","value":-17576700000,"profit":false},{"date":"2024-12-31","value":-5228600000,"profit":false}]
EPS (Diluted)(0.00)(1.87)(1.01)(5.59)0.25[{"date":"2020-12-31","value":-0.98,"profit":false},{"date":"2021-12-31","value":-762.33,"profit":false},{"date":"2022-12-31","value":-411.74,"profit":false},{"date":"2023-12-31","value":-2278.84,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

GeneDx Holdings Corp. Ratios

GeneDx Holdings Corp. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

WGS
Cash Ratio 1.77
Current Ratio 2.71
Quick Ratio 2.59

GeneDx Holdings Corp. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

WGS
ROA (LTM) 1.62%
ROE (LTM) 0.84%

GeneDx Holdings Corp. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

WGS
Debt Ratio Lower is generally better. Negative is bad. 0.41
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.59

GeneDx Holdings Corp. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

WGS
Trailing PE 819.55
Forward PE 77.52
P/S (TTM) 6.48
P/B 8.92
Price/FCF 272
EV/R 6.37
EV/Ebitda 75.71

FAQs

What is GeneDx Holdings Corp. share price today?

GeneDx Holdings Corp. (WGS) share price today is $92.04

Can Indians buy GeneDx Holdings Corp. shares?

Yes, Indians can buy shares of GeneDx Holdings Corp. (WGS) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in WGS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of GeneDx Holdings Corp. be purchased?

Yes, you can purchase fractional shares of GeneDx Holdings Corp. (WGS) via the Vested app. You can start investing in GeneDx Holdings Corp. (WGS) with a minimum investment of $1.

How to invest in GeneDx Holdings Corp. shares from India?

You can invest in shares of GeneDx Holdings Corp. (WGS) via Vested in three simple steps:

  • Click on Sign Up or Invest in WGS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in GeneDx Holdings Corp. shares
What is GeneDx Holdings Corp. 52-week high and low stock price?

The 52-week high price of GeneDx Holdings Corp. (WGS) is $170.87. The 52-week low price of GeneDx Holdings Corp. (WGS) is $55.17.

What is GeneDx Holdings Corp. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of GeneDx Holdings Corp. (WGS) is 819.5455

What is GeneDx Holdings Corp. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of GeneDx Holdings Corp. (WGS) is 8.92

What is GeneDx Holdings Corp. dividend yield?

The dividend yield of GeneDx Holdings Corp. (WGS) is 0.00%

What is the Market Cap of GeneDx Holdings Corp.?

The market capitalization of GeneDx Holdings Corp. (WGS) is $2.63B

What is GeneDx Holdings Corp.'s stock symbol?

The stock symbol (or ticker) of GeneDx Holdings Corp. is WGS

How Can Investors Use GeneDx Holdings Corp. Share Price Data for Long-Term Investment Decisions?

Consider the share price of GeneDx Holdings Corp. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether GeneDx Holdings Corp. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from GeneDx Holdings Corp. shares for Indian investors?

When investing in GeneDx Holdings Corp. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the GeneDx Holdings Corp. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare GeneDx Holdings Corp. share price with other stocks in the same sector?

Rather than merely checking the share price of GeneDx Holdings Corp. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that GeneDx Holdings Corp. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top